New Zealand Health Terminology Service (NZHTS) Implementation Guide
0.1.0 - ci-build

New Zealand Health Terminology Service (NZHTS) Implementation Guide, published by Health New Zealand | Te Whatu Ora. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/daniel-thomson/nzhts/ and changes regularly. See the Directory of published versions

ValueSet: NZ WHO breast invasive histology

Official URL: https://nzhts.digital.health.nz/fhir/ValueSet/canshare-who-breast-invasive-histology Version: 0.1.0
Active as of 2024-11-11 Computable Name: canshare-who-breast-invasive-histology
Other Identifiers: http://canshare.co.nz/fhir/NamingSystem/valuesets#canshare-who-breast-invasive-histology

Histologies used for invasive breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

Generated Narrative: ValueSet canshare-who-breast-invasive-histology

version: 1; Last updated: 2024-11-05 17:10:45+1300; Language: en-x-sctlang-23162100-0210105

  • Include codes fromhttp://snomed.info/sct where constraint = ^303031000210102 |New Zealand WHO classification of tumours (5th edition) breast invasive carcinoma histology reference set| OR ^ 303061000210106 |New Zealand WHO classification of tumours (5th edition) breast neuroendocrine histology reference set| OR 74964007 |Other|

 

Expansion

Generated Narrative: ValueSet canshare-who-breast-invasive-histology

version: 1; Last updated: 2024-11-05 17:10:45+1300; Language: en-x-sctlang-23162100-0210105

Expansion based on SNOMED CT 21000210109 edition 01-Oct 2024

This value set contains 34 concepts

CodeSystemDisplay - English (English, en)
  397241000210107http://snomed.info/sctAcinic cell carcinoma
  11671000http://snomed.info/sctAdenoid cystic carcinoma
  703644009http://snomed.info/sctAdenomyoepithelioma with carcinoma
  863926008http://snomed.info/sctAngiosarcoma
  384951004http://snomed.info/sctCarcinoma of salivary gland type
  476461000210108http://snomed.info/sctCarcinoma with apocrine differentiation
  30156004http://snomed.info/sctCribriform carcinoma
  703547006http://snomed.info/sctEncapsulated papillary carcinoma with invasion
  9618003http://snomed.info/sctEpithelial-myoepithelial carcinoma
  13238004http://snomed.info/sctGranular cell tumour, malignant
  82711006http://snomed.info/sctInfiltrating duct carcinoma
  64524002http://snomed.info/sctIntraductal papillary adenocarcinoma with invasion
  703578005http://snomed.info/sctInvasive micropapillary carcinoma of breast
  128628002http://snomed.info/sctLarge cell neuroendocrine carcinoma
  1163022006http://snomed.info/sctLeiomyosarcoma
  1162815008http://snomed.info/sctLiposarcoma
  89740008http://snomed.info/sctLobular carcinoma
  87913009http://snomed.info/sctMalignant phyllodes tumour
  128705006http://snomed.info/sctMetaplastic carcinoma
  285051000210103http://snomed.info/sctMicroinvasive malignant epithelial neoplasm
  72495009http://snomed.info/sctMucinous adenocarcinoma
  79143006http://snomed.info/sctMucinous cystadenocarcinoma
  4079000http://snomed.info/sctMucoepidermoid carcinoma
  1286767006http://snomed.info/sctNeuroendocrine carcinoma
  74964007http://snomed.info/sctOther
  2985005http://snomed.info/sctPaget's disease, mammary
  285071000210106http://snomed.info/sctPolymorphous malignant adenomatous neoplasm
  285111000210101http://snomed.info/sctPostradiation angiosarcoma
  285061000210100http://snomed.info/sctSecretory malignant epithelial neoplasm
  74364000http://snomed.info/sctSmall cell neuroendocrine carcinoma
  703594003http://snomed.info/sctSolid papillary carcinoma with invasion
  285081000210108http://snomed.info/sctTall cell carcinoma with reversed polarity
  4631006http://snomed.info/sctTubular adenocarcinoma
  1286768001http://snomed.info/sctWell-differentiated neuroendocrine tumour

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code